• Revenue up 824.6% to US$1.89m
• Loss up 0.2% to US$6.86m
• Signed 36 new agreements worth US$2.3m

Enlitic, Inc. reported its financial results for the half-year ended 30 June 2025. Revenue from ordinary activities increased by 824.6% to US$1,889,254, while loss from ordinary activities after tax was up 0.2% to US$6,862,114. The loss for the Group amounted to US$6,862,114, up 0.2% from the previous corresponding period. Enlitic is developing and commercialising AI software products that manage medical imaging data in radiology and licenses such products to healthcare providers. The Group primarily generates revenue from a subscription-based revenue model and project-based migrations. Enlitic signed 36 new agreements in the first half of 2025 with a total contract value of US$2.3m. For the 6 months ended 30 June 2025, the Group reported an increase in customer license agreement revenue of 74.3% to US$355k and migration services revenue of US$1.45m. Operating expenses increased by approximately 15.4% to US$8.2m, primarily due to the acquisition of Laitek. The loss before income tax expense increased to US$6.9 million. As a result of the loss and net cash outflows, there is a material uncertainty on whether the Group can continue as a going concern, though the Directors consider that the Group will continue as a going concern.